Beatrix Stelte-Ludwig

Beatrix Stelte-Ludwig is the Executive Vice President of Biology of Vincerx Pharma, Inc. Before joining Vincerx, Dr. Stelte-Ludwig was Head of Functional Assays at Bayer AG and was part of their R&D organization for over 30 years. During her time at Bayer, she identified preclinical candidates in different indications, ranging from cardiovascular diseases to oncology. Dr. Stelte-Ludwig authored/co-authored over 50 patents/patent applications and contributed to eight IND filings. In addition, she relocated Bayer’s urology department from Japan to Germany and was part of the team establishing the new biologics division within Bayer. Since 2007 her research has focused on antibody-drug conjugates (ADCs) including identification of targets, the establishment of numerous assays for mode-of-action studies, and evaluation of new payload classes including the KSPi platform. As a scientific ambassador of the “Life Science Innovation” community, Dr. Stelte-Ludwig was also involved in driving innovation and new technologies via collaboration with international academic partners and mentoring young scientists.

Dr. Stelte-Ludwig received her doctorate in chemistry/biochemistry from the Westfälische Wilhelms-Universität Münster under the mentorship of Prof Witzel. As a recipient of the German Research Foundation scholarship, she pursued her postdoctoral research fellowship at Harvard University in the group of Dr. Jack L Strominger.